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Abstract
Background: Ischemic stroke is the most common cause of disability in North America and in
addition to the generally accepted risk factors, there is increasing evidence for the potential
pathophysiological role of genes. One of these genes, the endothelial nitric oxide synthase gene
(NOS3) has been reported as a genetic risk factor for ischemic stroke. To independently confirm
and extend the results of these previous reports, we investigated this gene as a risk factor for
stroke in an ethnically diverse study population.
Methods:  Using the TOAST classification, we characterized and studied 377 patients with
ischemic stroke. We genotyped two common variants in the NOS3 gene, the intron 4 insertion/
deletion and an exonic single nucleotide polymorphism (SNP), G894T, in these patients and
compared them with 502 controls. Chi-square or Fisher's exact tests were used to examine allele
effects on stroke and stroke subtypes. Logistic regression analysis was used to adjust for
confounding covariate effects.
Results:  All genotypes are in Hardy-Weinberg equilibrium except for intron 4c, which is
overrepresented in ischemic stroke patients. In pooled analysis of all patients, intron 4c, but not
intron 4a, intron 4b or G894T alleles are associated with stroke (p < 0.01). In subgroup analysis by
race, the intron 4c allele is most strongly associated with large artery ischemic stroke in African
Americans (p < 0.01).
Conclusion: We are unable to confirm previous reports of an association of the intron 4a or the
G894T alleles with ischemic stroke. However, although limited by a relatively small sample size, our
study suggests a potentially important role of the intron 4c allele as a genetic marker of ischemic
stroke in African Americans.
Background
Ischemic stroke is the leading cause of disability in North
America and the third most common cause of death [1,2].
Since age is a major risk factor for stroke, as the popula-
tion ages, the burden from this disease will continue to
increase. In addition to the commonly accepted risk fac-
tors, there is increasing evidence for the role of genes in
the pathophysiology of cerebrovascular disease [3]. The
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endothelial nitric oxide synthase gene, (NOS3), has been
the focus of recent investigations as a potential genetic risk
factor in the development of ischemic stroke [4-6].
The NOS3 gene encodes an isozyme of nitric oxide syn-
thase that, in turn, catalyzes the generation of nitric oxide
(NO). The release of NO by endothelial cells mediates
vascular relaxation in response to vasoactive substances
and shear stress. In addition, it mediates antiproliferative
and antithrombotic action by inhibiting vascular smooth
muscle cell proliferation, monocyte adhesion, platelet
aggregation, and thrombosis [7]. This participation of the
NOS3gene in the physiology of the vasculature makes it a
biologically plausible candidate for study as a susceptibil-
ity gene in ischemic stroke.
A genetic contribution of NOS3 to plasma levels of NO
has been reported [8]. Furthermore, two potentially bio-
logically relevant genetic polymorphisms have been stud-
ied. The first is an intron 4 insertion/deletion or the
variable number tandem repeat (VNTR) polymorphism
and the second is an exonic single nucleotide polymor-
phism (SNP), G894T (Glu298Asp) [6]. The intron 4
VNTR consists of repeats of a 27-bp consensus sequence,
which may be repeated 4 times (intron 4a allele), 5 times
(intron 4b allele) or 6 times (intron 4c allele)[4].
Although the results are conflicting, there are reports
implicating variants in both these polymorphisms in the
development of ischemic stroke [4-6]. To confirm and
extend the results of these studies, we investigated both
polymorphisms as susceptibility loci for ischemic stroke
in an ethnically diverse population of patients.
Methods
Human Subjects
We studied 377 patients admitted to the stroke unit at
New Jersey Neuroscience Institute/John F. Kennedy Hos-
pital, Edison, New Jersey. All patients were confirmed to
have suffered an ischemic stroke with imaging data, either
by cerebral MRI or CT imaging. In addition, 502 controls
patients with no clinical or radiological evidence of cere-
brovascular disease were recruited from local family prac-
tice offices and from patients evaluated at the New Jersey
Neuroscience Institute, Edison, New Jersey. All patients
were entered into a stroke database recording the demo-
graphic and clinical data (Table 1). Strokes were catego-
rized according to the Trial of ORG 10172 in Acute Stroke
Treatment (TOAST) [9] and Oxfordshire criteria [10]. Race
was defined by self-report, however, all patients and con-
trols were under the care of physicians who provided
independent reporting. Any discrepancies were resolved
by direct communication with the patient or family.
Blood samples were obtained by policies and procedures
approved by the local Institutional Review Board.
Genetic Materials and Methods
DNA was extracted from a blood sample by standard
methods (Gentra Systems, Minneapolis, MN). Genotyp-
ing was performed by polymerase chain reaction (PCR) in
which all reactions were performed in a total volume of
50 μl, using 2.5 U of Ampli-Taq (Promega); 600 μM of a
dNTP mix and 40 ng of DNA template. The intron 4 pol-
ymorphism genotyping was performed as previously
described [4]. The allele sizes, a-393 bp, b-420 bp and c-
447 bp were determined by gel electrophoresis. The
G894T polymorphism was genotyped by PCR employed
previously published conditions and primers [6]. The
products were digested to completion with Mbo1 (New
England Biolabs) and visualized in a 6% polyacrylamide
gel. For both polymorphisms, the reliability of the geno-
typing was confirmed by direct sequencing of more than
20 randomly chosen samples of each genotype.
Statistical Analysis
The chi-square or Fisher's exact tests were used to examine
the allelic effect on stroke and stroke subtypes. Logistic
regression analysis was employed to adjust for the con-
founding effects of covariates. Covariates in the regression
model included age, gender, diabetes and hypertension.
Smoking status (ex- and current smoker vs. non-smoker)
Table 1: The clinical parameters of stroke and control groups.
Control group 
(n = 502)
Case group 
(n = 377)
Age (yrs) 65.32 ± 14.83 69.92 ± 13.52 †
Gender (male, %) 41.2% 48.3%*
Hypertension (%) 55.1% 76.0%†
Diabetes (%) 24.6% 37.4%†
Ex-smoker/Current smoker (%) 8.6%/17.7% 8.7%/17.9%
Race (Caucasian/African American/Asian-Indian/Hispanic/Asian-
oriental/Others) (%)
81.7%/8.4%/3.0%/
3.8%/0.8%/2.4%)
68.4%/11.9%/
5.8%/6.9%/
4.0%/2.9%)†
TOAST classification
Cardioembolism NA 24.1%
Large artery atherosclerosis NA 31.8%
Small vessel occlusion NA 24.1%
Others / unknown NA 19.9%
Glu298Asp allele distribution G/
T (2n)
482/198 460/194
Intron 4 VNTR allele 
distribution a/b/c (2n)
164/830/4 127/590/15†
Caucasian 126/688/2 87/410/3
African American 23/57/2 20/57/11*
Asian-Indian 3/27/0 7/36/1
Hispanic 5/33/0 9/41/0
Asian-Oriental 2/6/0 1/27/0
Others 5/19/0 3/19/0
*p < 0.05, †p < 0.01, the clinical data were expressed as mean ± SD 
where appropriate.
NA = not applicableBMC Medical Genetics 2007, 8:76 http://www.biomedcentral.com/1471-2350/8/76
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was not significantly related to disease and was excluded
from the logistic regression analysis.
Results
The clinical and genetic data are presented in Table 1.
Genotyping data for the Glu298Asp SNP was obtained on
340/502 controls and 327/377 cases and for the intron 4
VNTR polymorphism, on 499/502 controls and 366/377
cases. On some of the samples, only one polymorphism
was genotyped. There were no genotyping failures.
The Glu298Asp SNP genotypes are in Hardy-Weinberg
equilibrium (HWE). Analysis of the intron 4 VNTR poly-
morphism shows that the control group is in HWE, but
not the cases due to the over represented intron 4c allele
in African American patients.
The common allele G of the G894T polymorphism has a
similar frequency between control and stroke group (71%
vs. 70%). Neither the G nor T allele of the Glu298Asp pol-
ymorphism is associated with higher stroke risk in either
the pooled data or in the subgroup analysis by stroke sub-
type or race (Table 2)
The common allele of the intron 4 VNTR polymorphism,
the "b" allele has a frequency of 81% in cases versus 83%
in control subjects. If the intron 4b allele is used as a ref-
erence, the distribution of the intron 4c allele is signifi-
cantly different between stroke patients and healthy
controls (2% in cases vs. 0.4% in controls, p = 0.001). Fur-
thermore, the frequency of this allele varies across differ-
ent ethnic groups with the highest prevalence (7.6%) in
African- American patients. Overall, the intron 4c allele
increases the risk of stroke 5.3 fold compared to the b
allele (OR = 5.3, p = 0.001, 95% C.I. 1.9–18.6). Stroke
subtype analysis using the TOAST classification system
shows that the c allele effect exclusively appears in the
large artery subtype.
The genetic effect may be confounded by race if the data is
pooled from all ethnic groups and analyzed as a single
population. Therefore, we performed an race-specific
analysis which shows that African Americans with stroke
have a significantly higher prevalence of intron 4c allele
than controls (12.5% vs. 2.4%, p = 0.018). The c allele
increases the risk for stroke by 5.5 fold compared with the
b allele. This increased risk appears to be limited to those
who suffered a stroke secondary to large artery athero-
thrombosis but not other subtypes of stroke. In Cauca-
sians, the intron 4c allele is also more prevalent in
patients with the large artery subtype (1.9% vs. 0.2%,
Fisher p = 0.032). However, given that this allele is
extremely rare in Caucasians, these results should be inter-
preted cautiously.
In Caucasians and African Americans, logistic regression
analysis was performed with adjustment for age, gender,
hypertension, and diabetes as covariates (Table 3). This
analysis showed the adjusted odds ratio of the c allele was
similar to the crude one. In other ethnic subgroups, the c
allele is too rare for any meaningful analysis.
Table 2: Allele frequencies of candidate genes among each stroke subtype.
Gene Races Allele Controls 2n (%) All Cases 2n (%) TOAST classification, 2n (%)
Large artery 
atherosclerosis
Small vessel 
occlusion
Cardio- embolism Others
Intron 4 
VNTR
All b 830 (83.2) 590 (80.6) 186 (78.2) 142 (80.7) 145 (83.3) 117 (81.3)
a 164 (16.4) 127 (17.3) 40 (16.8) 34 (19.3) 27 (15.5) 26 (18.1)
c 4 (0.4) 15 (2.0) † 12 (5.0) † 0 (0.0) 2 (1.1) 1 (0.7)
Caucasian b 688 (84.3) 410 (82.0) 129 (81.6) 100 (80.6) 112 (82.4) 69 (84.1)
a 126 (15.4) 87 (17.4) 26 (16.5) 24 (19.4) 24 (17.6) 13 (15.9)
c 2 (0.2) 3 (0.6) 3 (1.9) * 0 (0.0) 0 (0.0) 0 (0.0)
African 
American
b 57 (69.5) 57 (64.8) 13 (46.4) 12 (75.0) 16 (80.0) 16 (66.7)
a 23 (28.0) 20 (22.7) 7 (25.0) 4 (25.0) 2 (10.0) 7 (29.2)
c 2 (2.4) 11 (12.5) * 8 (28.6) † 0 (0.0) 2 (10.0) 1 (4.2)
Glu298Asp All G 482 (70.9) 460 (70.3) 151 (71.2) 111 (72.1) 99 (64.3) 99 (73.9)
T 198 (29.1) 194 (29.7) 61 (28.8) 43 (27.9) 55 (35.7) 35 (26.1)
Caucasian G 392 (68.8) 303 (67.6) 98 (67.1) 74 (69.8) 74 (61.7) 57 (75.0)
T 178 (31.2) 145 (32.4) 48 (32.9) 32 (30.2) 46 (38.3) 19 (25.0)
African 
American
G 44 (84.6) 59 (73.8) 20 (83.3) 13 (81.2) 10 (62.5) 16 (66.7)
T 8 (15.4) 21 (26.2) 4 (16.7) 3 (18.8) 6 (37.5) 8 (33.3)
*p < 0.05, †p < 0.01, 2n refers to the allele count.BMC Medical Genetics 2007, 8:76 http://www.biomedcentral.com/1471-2350/8/76
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Discussion
There have been previous studies of the G894T polymor-
phism in stroke. In French patients, an association
between the "G" allele of the G894T polymorphism was
found in patients with ischemic infarcts, especially lacu-
nar strokes [6]. This was not supported by investigations
of either Scottish or English patients [5,11]. Similar to
these latter studies, our results do not support an associa-
tion between the Glu298Asp polymorphism and stroke.
However, given the relatively small sample size of lacunar
strokes in our study population, our negative result is
must be interpreted with caution.
In a study of 364 Chinese patients and 516 controls, the
intron 4a allele was reported as an independent risk factor
for developing ischemic stroke [4]. In English patients,
this same allele showed a protective affect in the develop-
ment of small vessel disease [6]. In contrast to the study of
Chinese patients, our analysis shows no association of the
4a allele with stroke. Interestingly, our investigation does
show an association of the intron 4c allele and stroke,
especially in African Americans.
The frequency of the intron 4c allele depends upon the
ethnic make up of the population. In a study of 1,038 Ger-
man patients with coronary artery disease and/or hyper-
tension, the c allele was rare, present in only 5 individuals
(0.005%) [12]. In the Chinese, this allele appears to be
even less common and was not observed in any of the 880
ischemic stroke patients/controls genotyped [4]. In an
investigation of the relationship between asthma and the
intron 4 polymorphisms, it was noted that the frequency
of the c allele was 3/390 (0.8%) in Caucasians versus 27/
510 (5.3%) in African Americans [13]. Our analysis of the
epidemiology of the intron 4 alleles is comparable to the
data obtained in these studies and indicates a higher fre-
quency of the c allele among African-Americans (Tables 1
and 2).
There has been one report studying the NOS3 gene in a
biracial population of Caucasians and African-Americans
with ischemic stroke [14]. In that investigation, the NOS3
gene was analyzed by genotyping 3 polymorphisms in the
promoter in addition to the intron 4 and G894T alleles.
The study was conducted in young woman with ischemic
stroke with a sample size of 110 cases (46% African Amer-
ican) compared to 206 controls (38% African American).
It was reported that in African American women, two
SNPs in the NOS3  promoter but not the intron 4 or
G894T alleles were associated with ischemic stroke. How-
ever, further analysis of their data using the most common
b allele as the reference shows that the OR for the c allele
in African Americans was 4.76 (p = 0.041). This is similar
to our result and provides further support for the potential
importance of this polymorphism in ischemic stroke
among African Americans.
Although our results regarding intron 4c are suggestive,
they involve small sample sizes that in turn limits the sta-
tistical analysis used in power calculations (Table 3). Fur-
ther study with large samples sizes of African-American
patients with ischemic stroke will needed to confirm and
extend these results.
Conclusion
In contrast to some previous reports, our study fails to
confirm any association of the G894T or intron 4a poly-
morphisms with ischemic stroke. However, the results of
all these studies may be influenced by ethnic differences
in allele frequencies and genetic susceptibility. The impor-
Table 3: Crude and adjusted odd ratios for stroke risk factors and gene in logistic regression analysis.
Risk factors Overall Caucasian African American
Crude O.R. of intron 4 VNTR 
(cc+ac+bc vs. aa+ab+bb)
3.84 (1.21 – 12.14), p = 0.02 1.64 (0.23 – 11.70), p = 0.62 4.33 (0.86 – 21.77), p = 0.08
Adjusted O.R. c allele of intron 4 VNTR 
(cc+ac+bc vs. aa+ab+bb)
3.54 (1.08 – 11.60), p = 0.04 1.48 (0.20 – 10.96), p = 0.70 5.06 (0.81 – 31.53), p = 0.08
Age 1.02 (1.01 – 1.03), p < 0.01 1.03 (1.01 – 1.04), p < 0.01 1.03 (0.99 – 1.07), p = 0.14
Gender 1.45 (1.09 – 1.93), p < 0.05 1.46 (1.05 – 2.04), p < 0.05 1.13 (0.38 – 3.42), p = 0.82
Hypertension 1.99 (1.44 – 2.75), p < 0.01 1.68 (1.15 – 2.45), p < 0.01 2.75 (0.88 – 8.64), p = 0.09
Diabetes 1.56 (1.14 – 2.12), p < 0.01 1.38 (0.96 – 1.99), p = 0.08 2.34 (0.81 – 6.75), p = 0.12
Crude O.R. of Glu298Asp (TT+GT vs. GG) 1.10 (0.81 – 1.49), p = 0.55 1.11(0.78 – 1.58), p = 0.56 2.25 (0.80 – 6.35), p = 0.13
Adjusted O.R. T allele of Glu298Asp (TT + 
GT vs. GG)
1.11 (0.81 – 1.53), p = 0.51 1.12 (0.78 – 1.61), p = 0.55 2.84 (0.79 – 10.14), p = 0.11
Age 1.01 (0.99 – 1.02), p = 0.06 1.02 (1.01 – 1.04), p < 0.05 1.04 (0.99 – 1.08), p = 0.09
Gender 1.39 (1.01 – 1.91), p = 0.05 1.44 (0.99 – 2.08), p = 0.05 1.10 (0.34 – 3.55), p = 0.87
Hypertension 1.96 (1.37 – 2.81), p < 0.01 1.65 (1.08 – 2.50), p < 0.05 2.72 (0.72 – 10.28), p = 0.14
Diabetes 1.54 (1.08 – 2.18), p < 0.05 1.41(0.93 – 2.13), p = 0.10 2.15 (0.59 – 7.90), p = 0.25
The 95% confidence interval of odds ratio (O.R.) was expressed in parentheses.Publish with BioMed Central    and   every 
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tance of such ethnic differences in these kinds of studies is
illustrated by our analysis showing an association of the
intron 4c allele with ischemic stroke in African-Ameri-
cans. Further study of the intron 4c allele in ischemic
stroke is warranted.
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